Abstract.
Most of the gastroprotective drugs which had been marketed in Japan were considered to have insufficient rationale for use as ulcer treatments. Such drugs may have a crucial role in maintaining mucosal integrity by the mechanisms other than inhibition of acid secretion. We re-evaluated the effect of gastroprotective drugs on gastric ulcer healing using current ICH E9 guidelines. We collected reports of pivotal trials on healing rate of gastric ulcer with 9 kinds of gastroprotective drugs submitted in New Drug Applications. In the comparative trial of cetraxate vs. placebo, the healing rate of gastric ulcer at 8-week endoscopy in the cetraxate was significantly higher than that in the placebo groups (88.6 % and 62.2 %, p = 0.0062). Non-inferiority to cetraxate was confirmed for 8 kinds of gastroprotective drugs. In conclusion, the superiority of cetraxate over placebo and non-inferiority to cetraxate for 7 drugs was established in the respect of effect on ulcer healing.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Additional information
Received and accepted 4 August 2006
Rights and permissions
About this article
Cite this article
Higuchi, K., Watanabe, T., Tanigawa, T. et al. Are gastroprotective drugs useful for gastric ulcer healing: Re-evaluation using current ICH E9 guidelines. Inflammopharmacol 15, 18–21 (2007). https://doi.org/10.1007/s10787-006-0300-y
Issue Date:
DOI: https://doi.org/10.1007/s10787-006-0300-y